Balchem Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Balchem heeft een totaal eigen vermogen van $1.2B en een totale schuld van $227.0M, wat de schuld-eigenvermogensverhouding op 19.3% brengt. De totale activa en totale passiva bedragen respectievelijk $1.6B en $419.7M. De EBIT Balchem is $164.2M waardoor de rentedekking 8.6 is. Het heeft contanten en kortetermijnbeleggingen van $73.7M.
Belangrijke informatie
19.3%
Verhouding schuld/eigen vermogen
US$227.00m
Schuld
| Rente dekkingsratio | 8.6x |
| Contant | US$73.69m |
| Aandelen | US$1.18b |
| Totaal verplichtingen | US$419.72m |
| Totaal activa | US$1.60b |
Recente financiële gezondheidsupdates
Is Balchem (NASDAQ:BCPC) Using Too Much Debt?
Sep 09
These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well
Feb 18Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet
Oct 19Is Balchem (NASDAQ:BCPC) A Risky Investment?
Jul 19We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt
Mar 14Is Balchem (NASDAQ:BCPC) A Risky Investment?
Dec 13Recent updates
Balchem Corporation's (NASDAQ:BCPC) Earnings Haven't Escaped The Attention Of Investors
Nov 22Balchem's Q3 Shows Record Earnings And Valuation Pressure
Oct 28Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return
Oct 21Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Oct 07Is Balchem (NASDAQ:BCPC) Using Too Much Debt?
Sep 09Here's Why We Think Balchem (NASDAQ:BCPC) Might Deserve Your Attention Today
Aug 27Balchem Corporation's (NASDAQ:BCPC) Shares May Have Run Too Fast Too Soon
Aug 13Earnings Update: Here's Why Analysts Just Lifted Their Balchem Corporation (NASDAQ:BCPC) Price Target To US$184
Jul 31Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing
Jun 29Shareholders Will Most Likely Find Balchem Corporation's (NASDAQ:BCPC) CEO Compensation Acceptable
Jun 15Calculating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
Jun 10Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching
May 26Balchem: A Tale Of Two Businesses
May 10Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear
Mar 21Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value
Mar 05Balchem: Potential Turnaround Is In The Price
Feb 21These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well
Feb 18Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled
Jan 03Balchem Corporation's (NASDAQ:BCPC) P/E Is On The Mark
Dec 19Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Nov 20Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet
Oct 19The Returns At Balchem (NASDAQ:BCPC) Aren't Growing
Sep 09A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
Aug 22Is Balchem (NASDAQ:BCPC) A Risky Investment?
Jul 19Some Investors May Be Worried About Balchem's (NASDAQ:BCPC) Returns On Capital
May 28Calculating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
May 12Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?
Apr 12We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt
Mar 14Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns
Jan 11Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching
Dec 29Is Balchem (NASDAQ:BCPC) A Risky Investment?
Dec 13Balchem Corporation (NASDAQ:BCPC) Shares Could Be 26% Above Their Intrinsic Value Estimate
Nov 29Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return
Sep 20Balchem: Acquisitions And Cost Pressures Draw Attention
Sep 12Balchem (NASDAQ:BCPC) Seems To Use Debt Rather Sparingly
Sep 05Balchem to acquire Cardinal Associates or Bergstrom Nutrition
Aug 30Is Balchem Corporation (NASDAQ:BCPC) Worth US$138 Based On Its Intrinsic Value?
Aug 22Should You Be Adding Balchem (NASDAQ:BCPC) To Your Watchlist Today?
Aug 08Balchem Q2 2022 Earnings Preview
Jul 28Balchem: On The M&A Road Again
Jun 28Balchem: A New Growth Stage Is Just Beginning
Jun 02Slowing Rates Of Return At Balchem (NASDAQ:BCPC) Leave Little Room For Excitement
May 30Balchem Corporation's (NASDAQ:BCPC) Intrinsic Value Is Potentially 17% Below Its Share Price
May 18Does Balchem (NASDAQ:BCPC) Deserve A Spot On Your Watchlist?
May 02Does Balchem (NASDAQ:BCPC) Have A Healthy Balance Sheet?
Mar 28Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns
Feb 26Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $326.0M ) BCPC } overtreffen de korte termijn passiva ( $109.4M ).
Langlopende schulden: De kortetermijnactiva BCPC ( $326.0M ) overtreffen de langetermijnschulden ( $310.3M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 13% ) BCPC wordt als voldoende beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van BCPC is de afgelopen 5 jaar gedaald van 30.1% naar 19.3%.
Schuldendekking: De schuld van BCPC wordt goed gedekt door de operationele kasstroom ( 86.8% ).
Rentedekking: De rentebetalingen op de schuld van BCPC worden goed gedekt door EBIT ( 8.6 x dekking).